Home > Insider Trading > Filing (0001179110-17-009133)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1651561	Tabula Rasa Healthcare Inc.	TRHC	Services-Business Services, Nec (7389)	465726437

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1685833	H Calvin Knowlton	228 Strawbridge Drive Suite 100 Moorestown NJ 08057	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2017-06-14	8,000	$14.02	907,117	No	4	S	Indirect	Held by spouse.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by spouse.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	918,362	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Orsula V. Knowlton on May 4, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.72 to $14.41, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4.
Orsula Knowlton received a restricted stock award of 267,268 shares of the Company's common stock on September 28, 2016. All such shares of common stock were scheduled to vest on May 31, 2017. Notwithstanding the foregoing, on June 12, 2017, the Company entered into an amendment to the restricted stock award with Orsula Knowlton and, pursuant thereto, all shares underlying such restricted stock award will now vest in full on May 31, 2018.
Dr. Knowlton received a restricted stock award of 337,307 shares of the Company's common stock on September 28, 2016. All such shares of common stock were scheduled to vest on May 31, 2017. Notwithstanding the foregoing, on June 12, 2017, the Company entered into an amendment to the restricted stock award with Dr. Knowlton and, pursuant thereto, all shares underlying such restricted stock award will now vest in full on May 31, 2018.